Advances in Pharmacological Sciences
Volume 2016 (2016), Article ID 8195381, 6 pages
http://dx.doi.org/10.1155/2016/8195381

Research Article

Cytotoxic Activity of Holothuria leucospilota Extract against Leishmania infantum In Vitro

Shahram Khademvatan,1,2 Alborz Eskandari,¹ Jasem Saki,1,3 and Masoud Foroutan-Rad³

¹Research Institute for Infectious Diseases of Digestive System, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
²Department of Medical Parasitology and Mycology and Cellular and Molecular Research Center, Urmia University of Medical Sciences, Urmia, Iran
³Department of Medical Parasitology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Received 15 November 2015; Accepted 27 January 2016

Academic Editor: Antonio Ferrer-Montiel

Copyright © 2016 Shahram Khademvatan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Leishmaniasis is a tropical parasitic infection. The resistance and toxicity issues are the major complications and remain significant consequences related to the treatment of leishmaniasis with the recent and classical drugs. Thus there is an immediate requirement to develop new compounds for the treatment of this protozoan disease. Sea cucumbers or holothurians are potentially presented as the marine sources of antimicrobial and cytotoxic compounds. The aim of this study was investigation of in vitro antileishmanial activity of methanol extract of body wall, coelomic fluid, and cuvierian organs of Holothuria leucospilota obtained from coastal parts of Persian Gulf against Leishmania infantum promastigotes and axenic amastigotes. The colorimetric MTT assay was used to determine L. infantum promastigotes and axenic amastigotes viability at different concentrations of the extracts and drug control (Glucantime®) at time dependent manner and the results are represented as IC₅₀ (50% of inhibitory concentration). Coelomic fluid was the most active extract among the three different extracts of H. leucospilota against L. infantum promastigotes and axenic amastigotes with IC₅₀s of 62.33 μg/mL and 22.4 μg/mL and 73 μg/mL and 46 μg/mL at 48 and 72 hours after treatment, respectively. Cuvierian organs extract showed less toxicity with IC₅₀s more than 1000 μg/mL for both Leishmania infantum axenic amastigotes and promastigotes forms after 48 and 72 hours of exposure. Results acquired from the present study propose that the sea cucumber H. leucospilota may be a provoking source of antileishmanial compounds and could be a lead source in the development of the potent antileishmanial and cytotoxic drugs.

1. Introduction

Leishmaniasis is a protozoan parasitic infectious disease transmitted by the bite of certain phlebotomine sand flies and causing comprehensive morbidity and mortality in tropical and subtropical regions around the world, especially in most developing countries. It is caused by genus Leishmania and occurs in at least three major clinical manifestations: visceral, cutaneous, and mucocutaneous. The symptoms are ranging from self-healing ulcerative lesions to life threatening visceral leishmaniasis [1]. The occurrences of leishmaniasis could increase in the lack of an efficient vaccine and vector control problems and immunodeficiency caused by several conditions and the main current antileishmanial drugs administration limitations such as toxicity, resistance, parenteral administration, variable efficacy, and long schedules of their administration. Therefore, there is an immediate need for new compounds for the treatment of the leishmaniasis [2, 3].

Sea cucumbers or holothurians are marine invertebrate animals from the class Holothuroidea (echinoderms phylogenetically) which is located in the benthic places and deep seas all over the world [4]. They are utilized as human food sources, particularly in some districts of Asia. Because of the growing global need for food and medicine, many strains of sea cucumbers have been used [5]. These animals have a high percentage of protein with less cholesterol and are used as foodstuffs in various cuisines [6]. It has been reported in different studies that they have several bioactive compounds with biological activities. Antibacterial, antiviral, antioxidant, cytotoxicity, antitumor, and anticancer activities of the sea cucumber extracts and holothurians derived compounds have been reported previously [6]. It has been demonstrated that various protozoa and single-celled eukaryotes comprising Leishmania parasites display programmed cell death (PCD) mechanism similarities with the PCD of multicellular organisms exposed to certain cytotoxic agent [7]. Researchers demonstrated that sea cucumbers induce apoptotic cell death on various cancer cell lines [8–11]. Antileishmanial activity of these extracts and their bioactive compounds have not been studied so far particularly. This study was designed to investigate in vitro antileishmanial activity of various extracts of H. leucospilota against L. infantum promastigotes and axenic amastigotes in comparison to drug control Glucantime using colorimetric MTT assay.

2. Materials and Methods

2.1. Collection, Processing, and Extraction of Sea Cucumber

H. leucospilota samples were harvested freshly from the Persian Gulf, around the coastal cities of Qeshm and Kharg Islands, Iran. Samples were washed out and cleaned with fresh distilled water to detach detritus and external particles and stored at −20°C until the next usage in agreement with food and agriculture of the United Nations scale method [12]. Then the three parts of H. leucospilota (coelomic fluid, cuvierian organs, and body wall) were separated into several small pieces. Then, samples were kept at room temperature for two days to dry entirely and grinned into the fine powders. After that the different dried parts of H. leucospilota were extracted by maceration in appropriate quantities blending of methanol-water (50 : 50) and maintained for 16 hours. After that, the blend was filtered for two times. The filtrate was concentrated under vacuum conditions by rotary evaporation. Finally, to remove the solvents completely and increase the purity, all the extracts were dried by the freeze dryer. All other chemicals were purchased from Sigma (Sigma, Chemical Co., St. Louis, MO, USA).

2.2. Promastigote and Amastigote Culture

Standard strain of L. infantum (MCAN/IR/96/LONDON49) originally was supplied by Dr. Mohebali (Tehran University of Medical Sciences). Shortly, 5 × 10⁵ promastigotes/mL were cultured at °C in RPMI 1640 medium with 10% of heat deactivated fetal calf serum (FCS), 2 mM L-glutamine, 100 mg/mL streptomycin, and 100 U/mL penicillin and after 96 hours promastigotes were subcultured at logarithmic phase and densities of 1 × 10⁶ cells/mL. Promastigotes were placed in 96-well culture plates at cell density of 1 × 10⁵ cells/100 μL/well and treated with different concentrations of reference drug and H. leucospilota extracts were carried out in triplicate. When promastigotes grew up to logarithmic phase (1 × 10⁶ cells/mL), 100 μL of suspension was transferred to a sterile falcon tube and 100 μL of BHI medium with 10% of heat deactivated FCS and 1% of streptomycin and penicillin added to it. The promastigotes were centrifuged at stationary phase of growth and then supernatant was removed carefully and sediments were suspended in Schneider’s medium (acidify with succinic acid) and incubated at °C for 48 hours. The promastigotes were altered to amastigotes form and treated with different concentrations of reference drug and H. leucospilota extracts were carried out in triplicate.

2.3. Antileishmanial Assay

Colorimetric MTT assay was performed to determine antileishmanial activity of different extracts of sea cucumber and drug control. After the incubation periods at °C for 24, 48, and 72 hours, 25 μL of syringe filtrated MTT work solution (5 mg/mL) was added to wells and incubated at °C for 4 hours. The supernatants were removed completely without interrupting the cell sediments, and 100 μL of dimethyl sulfoxide (DMSO) was added to each well. After the microplate shaking for 15 min, the absorbance was recorded at 570 nm on a microplate reader. The viability of treated and untreated promastigotes was studied by measuring conversion of MTT to the reduced form that indicates cell viability, and a decline in the amount of MTT alteration is a toxicity indication to the promastigotes [13–15]. Relative numbers of viable cells are prescribed by the following equation:

where , , and are the absorbance of treated, untreated, and blank samples, respectively, which were studied as means of triplicate. IC₅₀ (concentration of drug decreasing 50% of cell viability) was prescribed by linear regression analysis [13]. Reference drug, Glucantime® (Meglumine antimoniate), was kept at 4°C and diluted with RPMI 1640 medium at the time of incubation. Sterile distilled water was used to prepare stock solutions of all extracts of H. leucospilota and twofold dilution method was used to prepare serial concentration of the extracts (156 × 10³–4.75 μg/mL) to make working solutions.

2.4. Determination of Morphological Changes of Promastigotes

Promastigotes treated with H. leucospilota extracts (IC₅₀) were tested to perceive morphological changes. Promastigotes were centrifuged for 10 min at 1000 g and supernatant was removed carefully and the sediments were suspended in PBS. Morphological alteration was studied after treatment under light microscope on the magnification of ×100 at different time points from 0 to 72 hours [13, 16].

2.5. Statistical Analysis

All the results were expressed as the mean values of three independent experiments ± SE by linear regression. The data were analyzed by SPSS 21.

3. Results

Methanol extract of H. leucospilota demonstrated significant leishmanicidal activity against L. infantum promastigotes in vitro at different concentrations and time dependent manner (Figures 1 and 2). The in vitro antileishmanial effects of H. leucospilota extracts and Glucantime against L. infantum promastigotes and amastigotes are shown in Table 1. These results revealed that of all sea cucumber extracts body wall and coelomic fluid of H. leucospilota have antileishmanial activity with IC₅₀s of 53.5 μg/mL and 22.41 μg/mL after 72 hours of incubation, while cuvierian organs extracts have shown no significant leishmanicidal activity on extracellular form of L. infantum. Coelomic fluid extract of this sea cucumber was the most active extract against both extra- and intracellular forms of L. infantum with IC₅₀s of 62.33 μg/mL and 22.41 μg/mL and 73.1 μg/mL and 46.21 μg/mL after 48 and 72 hours of exposure, respectively. Promastigotes survival for body wall as well as coelomic fluid extract at this concentration point was 90.24%, 79.4%, and 57.45% and 82.13%, 59.66%, and 26.43% after 24, 48, and 72 hours of treatment, respectively (Table 1 and Figure 1).

Table 1: In vitro antileishmanial activity of H. leucospilota and reference drug Glucantime against L. infantum promastigotes and amastigotes in different time points.

Test sample/drug
Promastigotes
Survival (%)
Amastigotes

(µg/mL)
(µg/mL)

24 h
48 h
72 h
50 µg/mL
24 h
48 h
72 h

Body wall extract

Cuvierian organs
>1000
>1000
>1000
>1000
>1000
>1000
>1000

Coelomic fluid

Glucantime

Data are presented as the means SD of results from triplicate experiments.

Survival of promastigotes after 72 hours of exposure to 50 g/mL concentration of test compounds.

Figure 1: Time dependent leishmanicidal activity of H. leucospilota extracts against L. infantum promastigotes. The results are shown as a percentage of parasite killing from three independent experiments performed as triplicate (mean ± SE) using MTT assay after treatment with 50 μg/mL of each sample tested.

Figure 2: Concentration-dependent leishmanicidal activity of H. leucospilota extracts against L. infantum promastigotes. The results are shown as a percentage of parasite killing from three independent experiments performed as triplicate (mean ± SE) using MTT assay after 72 hours of exposure.

The morphological alterations of treated promastigotes with or without 22.5 μg/mL (IC₅₀) of coelomic fluid of H. leucospilota were carried out in the logarithmic growth phase of L. infantum promastigotes and studied under a light microscope at 8 h intervals after coelomic fluid extract adding up to 72 hours. The number of promastigotes at the inception of treatment with coelomic extract was one million/mL approximately, and the treated promastigotes grew up to 4 million/mL, 16 hours after exposure, and the live promastigotes quantity decreased in 16 to 72 hours after exposure in comparison to untreated samples, which grew up to 12-13 million/mL up to 120 hours. Evaluation of the microscopic changes of promastigotes exhibited that promastigotes began to contract at 8 hours after treatment of L. infantum promastigotes (Figure 3). At the end of 72 hours of exposure, all the treated promastigotes compared with the control promastigotes exhibited cytoplasmic shrinkage and size diminishing (Figure 4).

Figure 3: Antileishmanial activities of coelomic fluid extract of H. leucospilota against L. infantum promastigotes. Number of promastigotes treated with or without coelomic fluid (22.5 μg/mL) at different time point after 48 h.

Figure 4: Morphological changes of L. infantum promastigotes treated with coelomic fluid extract (22.5 μg/mL) at different time point after 24, 48, and 72 h.

4. Discussion

Nowadays pentavalent antimonial compounds are the most important drugs that are being used for treatment of leishmaniasis. The resistance and toxicity are the major complications and significant issues related to the treatment of leishmaniasis infection with these recent and classical drugs [2, 3].

Pharmacological activities such as antiproliferative, antioxidant, anti-inflammatory, anticoagulant, anticancer, antifungal, and antimicrobial activities of the bioactive compounds derived from benthic organisms, mainly from star-fish and sea cucumbers, have been examined in several studies previously [17–19]. Fatty acids of sea cucumber, containing arachidonic acid, docosahexaenoic acid, and eicosapentaenoic acid, appear to have a potential role in wound healing and tissue repairing [6]. For this reason, many parts of the world utilize sea cucumbers as a traditional treatment for burns and cuts [20, 21]. Furthermore, sea cucumber, due to possessing arginine, glycine, and glutamic amino acids ingredients, could contribute to the immunomodulatory activity [22]. Accordingly it is suggested that sea cucumber and its certain bioactive amino acid and fatty acid can improve immune system function [22] and lessen the duration of wound healing [21, 23]. It is suggested that certain molecules with anticancer activity at the pharmacological observation might be also suitable as antiprotozoal agents. Accordingly, several chemical and natural compounds have been examined against trypanosomatids and other single-celled parasites [3, 24]. Thus researchers indicated that sea cucumber can induce apoptotic cell death cytotoxicity effects on various cancer cell lines [8–11, 25]. Antifungal and antibacterial activities of sea cucumber H. leucospilota isolated from Persian Gulf have been studied recently in several studies, and they showed bactericidal and fungicidal effects [12]. Cytotoxic effect of this Persian Gulf sea cucumber extract against K-562 and WEHI-164 cancer cell lines has been examined, and results demonstrated that aqueous coelomic extracts of H. leucospilota have satisfactory levels of cytotoxicity effect against these two cancer cell lines [26].

In current research, the effectiveness of several concentrations of the H. leucospilota extract against L. infantum promastigotes as well as axenic amastigotes was examined. We have investigated the methanol extract of coelomic fluid of H. leucospilota that exhibited 73.56% inhibition of promastigotes after 72 hours of treatment with concentration of 50 μg/mL compared with Glucantime with 93.34% inhibition. Among all the three H. leucospilota extracts, coelomic fluid was the most active extract against extra- and intracellular forms of L. infantum after 48 and 72 hours of treatment. Although Glucantime showed highest activity against L. infantum promastigotes and amastigotes, the cuvierian organs extract with IC₅₀s > 1000 μg/mL was the lowest active extract on these extra- and intracellular forms of this parasite after 48 and 72 hours of treatment, respectively. Body wall extract was less effective than coelomic fluid at 24, 48, and 72 hours and 3 times less effective than Glucantime after 24 and 48 hours after treatment. Furthermore time-dependency after 24, 48, and 72 hours of exposure of extracts and drugs control to Leishmania promastigotes, as well as concentration-dependency at three values of 10, 50, and 250 μg/mL, was determined (Figures 1 and 2). These extracts reduced promastigotes viability at different concentrations in a concentration-dependent and time dependent manner.

5. Conclusion

This study revealed satisfactory level of in vitro activity of H. leucospilota against Leishmania parasite; however, in vivo leishmanicidal activities of this agent and its constituents should further be examined. Generally, leishmanicidal effect of extracts derived from this invertebrate holothurian may be due to the presence of bioactive components such as triterpene glycosides, concentrated mainly in the coelomic fluid in comparison with cuvierian organ with lesser activity. Finally, results obtained from this study propose that H. leucospilota could be sources of antiprotozoal compounds that could be used as a lead potent leishmanicidal agent.

Conflict of Interests

The authors declare no conflict of interests.

Acknowledgments

This study was supported by financial support from Research Institute for Infectious Diseases of Digestive System, Ahvaz Jundishapur University of Medical Sciences, Grant no. RDC-9413. Research Deputy, Ahvaz Jundishapur University of Medical Sciences, is acknowledged.

References

J. Alvar, I. D. Vélez, C. Bern et al., “Leishmaniasis worldwide and global estimates of its incidence,” PLoS ONE, vol. 7, no. 5, Article ID e35671, 2012.

J. Chakravarty and S. Sundar, “Drug resistance in leishmaniasis,” Journal of Global Infectious Diseases, vol. 2, no. 2, pp. 167–176, 2010.

M. Foroutan-Rad, K. Hazrati Tappeh, and S. Khademvatan, “Antileishmanial and immunomodulatory activity of Allium sativum (Garlic): a review,” Journal of Evidence-Based Complementary & Alternative Medicine, 2015.

A. M. Kerr and J. Kim, “Phylogeny of Holothuroidea (Echinodermata) inferred from morphology,” Zoological Journal of the Linnean Society, vol. 133, no. 1, pp. 63–81, 2001.

A. J. Lawrence, R. Afifi, M. Ahmed, S. Khalifa, and T. Paget, “Bioactivity as an options value of sea cucumbers in the Egyptian Red Sea,” Conservation Biology, vol. 24, no. 1, pp. 217–225, 2010.

S. Bordbar, F. Anwar, and N. Saari, “High-value components and bioactives from sea cucumbers for functional foods—a review,” Marine Drugs, vol. 9, no. 10, pp. 1761–1805, 2011.

A. Jiménez-Ruiz, J. F. Alzate, E. T. MacLeod, C. G. K. Lüder, N. Fasel, and H. Hurd, “Apoptotic markers in protozoan parasites,” Parasites and Vectors, vol. 3, article 104, 2010.

N. B. Janakiram, A. Mohammed, Y. Zhang et al., “Chemopreventive effects of Frondanol A5, a Cucumaria frondosa extract, against rat colon carcinogenesis and inhibition of human colon cancer cell growth,” Cancer Prevention Research, vol. 3, no. 1, pp. 82–91, 2010.

A. S. Silchenko, S. A. Avilov, V. I. Kalinin et al., “Constituents of the sea cucumber Cucumaria okhotensis. Structures of okhotosides B₁–B₃ and cytotoxic activities of some glycosides from this species,” Journal of Natural Products, vol. 71, no. 3, pp. 351–356, 2008.

X. Li, A. B. Roginsky, X.-Z. Ding et al., “Review of the apoptosis pathways in pancreatic cancer and the anti-apoptotic effects of the novel sea cucumber compound, frondoside A,” Annals of the New York Academy of Sciences, vol. 1138, no. 1, pp. 181–198, 2008.

T. Sugawara, N. Zaima, A. Yamamoto, S. Sakai, R. Noguchi, and T. Hirata, “Isolation of sphingoid bases of sea cucumber cerebrosides and their cytotoxicity against human colon cancer cells,” Bioscience, Biotechnology and Biochemistry, vol. 70, no. 12, pp. 2906–2912, 2006.

N. Adibpour, F. Nasr, F. Nematpour, A. Shakouri, and A. Ameri, “Antibacterial and antifungal activity of Holothuria leucospilota isolated from Persian Gulf and Oman Sea,” Jundishapur Journal of Microbiology, vol. 7, no. 1, Article ID e8708, 2014.

S. Khademvatan, N. Adibpour, A. Eskandari, S. Rezaee, M. Hashemitabar, and F. Rahim, “In silico and in vitro comparative activity of novel experimental derivatives against Leishmania major and Leishmania infantum promastigotes,” Experimental Parasitology, vol. 135, no. 2, pp. 208–216, 2013.

S. Khademvatan, M. J. Gharavi, F. Rahim, and J. Saki, “Miltefosine-induced apoptotic cell death on Leishmania major and L. tropica strains,” Korean Journal of Parasitology, vol. 49, no. 1, pp. 17–23, 2011.

E. Yousefi, A. Eskandari, M. Gharavi, and S. Khademvatan, “In vitro activity and cytotoxicity of Crocus sativus extract against Leihmania major (MRHO/IR/75/ER),” Infectious Disorders—Drug Targets, vol. 14, no. 1, pp. 56–60, 2014.

S. Allahdin, S. Khademvatan, M. Hashemitabar, and A. Eskandari, “In vitro activity of Camellia sinensis extracts against L. major and L. infantum promastigotes using the Colorometric MTT Assay,” Urmia Medical Journal, vol. 25, no. 10, pp. 893–900, 2014.

A. Lipton and D. I. Dhinakaran, “Pharmacological potentials of sea cucumber Holothuria atra extracts from the Indian Ocean,” Asian Journal of Biomedical and Pharmaceutical Sciences, vol. 4, no. 35, pp. 36–43, 2004.

O. Y. Althunibat, B. H. Ridzwan, M. Taher, J. Daud, S. J. A. Ichwan, and H. Qaralleh, “Antioxidant and cytotoxic properties of two sea cucumbers, Holothuria edulis lesson and Stichopus horrens Selenka,” Acta Biologica Hungarica, vol. 64, no. 1, pp. 10–20, 2013.

A. Mokhlesi, S. Saeidnia, A. R. Gohari et al., “Biological activities of the sea cucumber Holothuria leucospilota,” Asian Journal of Animal and Veterinary Advances, vol. 7, no. 3, pp. 243–249, 2012.

J. E. San Miguel-Ruiz and J. E. García-Arrarás, “Common cellular events occur during wound healing and organ regeneration in the sea cucumber Holothuria glaberrima,” BMC Developmental Biology, vol. 7, no. 1, article 115, 2007.

B. D. Fredalina, B. H. Ridzwan, A. A. Z. Abidin et al., “Fatty acid compositions in local sea cucumber, Stichopus chloronotus, for wound healing,” General Pharmacology, vol. 33, no. 4, pp. 337–340, 1999.

Q. Zhao, J. Wang, Y. Xue et al., “Comparative study on the bioactive components and immune function of three species of sea cucumber,” Journal of Fishery Sciences of China, vol. 15, no. 1, pp. 154–159, 2008.

D. N. Menton and A. Z. Eisen, “Cutaneous wound healing in the sea cucumber, Thyone briareus,” Journal of Morphology, vol. 141, no. 2, pp. 185–204, 1973.

T. R. Morais, P. Romoff, O. A. Fávero et al., “Anti-malarial, anti-trypanosomal, and anti-leishmanial activities of jacaranone isolated from Pentacalia desiderabilis (Vell.) Cuatrec. (Asteraceae),” Parasitology Research, vol. 110, no. 1, pp. 95–101, 2012.

M. Ogushi, Y. Yoshie-Stark, and T. Suzuki, “Apoptosis-inducing activity of hot water extracts from the sea cucumber in human colon tumor cells,” Food Science and Technology Research, vol. 12, no. 4, pp. 290–294, 2006.

M. Assarian, A. Rakhshan, A. Khodadadi, N. Adibpour, and S. Rezaee, “Evaluation of cytotoxicity of two Persian Gulf sea cucumber species extracts on K562 and Wehi-164 cell lines and blood granulocyte cells,” Research in Pharmaceutical Sciences, vol. 7, no. 5, p. S112, 2012.